The group’s principal activity is to provide medical products. The group’s provides tests for the detection of bacterial contaminants in blood components, tissues for transplantation and cellular therapies. The group’s products include pgd technology, red cell pgd test, cell therapy pgd test and platelet pgd test. The group was founded in 1999. The group operates from the United States.
